| Financial Year |
March 31 2023 |
| Monetary Funds |
144,813,647.86 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
76,844,755.23 |
| Accounts Receivable |
109,968,938.23 |
| Advances to Suppliers |
43,714,824.94 |
| Other Receivables |
2,468,260.70 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
410,484,946.39 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
7,652,199.52 |
| Total Current Assets |
797,889,622.87 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
1,064,069,154.90 |
| Under-construction Projects |
62,865,940.10 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
360,882,581.34 |
| R&D expenses |
73,987,214.87 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
5,745,425.89 |
| Deferred Income Tax Assets |
59,046,765.70 |
| Other Non-Current Assets |
7,750,469.00 |
| Sub-Total of Non-Current Assets |
1,645,994,946.16 |
| Total Assets |
2,443,884,569.03 |
| Short-Term Loans |
379,475,541.59 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
80,952,406.05 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
1,130,652.61 |
| Taxes Payable |
3,797,014.99 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
11,920,592.88 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
54,422,318.32 |
| Other Current Liabilities |
2,229.10 |
| Sub-Total of Current Liabilities |
532,711,290.90 |
| Long-term Loans |
197,520,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
3,843,492.15 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
431,036,471.49 |
| Total Liabilities |
963,747,762.39 |
| Paid-In Capital(Or Share Stock) |
653,120,000.00 |
| Capital Surplus |
331,165,293.91 |
| Surplus Reserve |
81,762,243.47 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
325,016,699.45 |
| Minority Stockholder's Interest |
81,605,451.06 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,398,531,355.58 |
| Owner's Equity（Stockholder's Equity） |
1,480,136,806.64 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,443,884,569.03 |
